Download MBBS Surgery Presentations 18 Disorders of Melanocytes Lecture Notes

Download MBBS (Bachelor of Medicine, Bachelor of Surgery) 1st Year, 2nd Year, 3rd Year and Final year Surgery 18 Disorders of Melanocytes PPT-Powerpoint Presentations and lecture notes










Disorders of Melanocytes

Melanoma

Nevus

Histopathology:

Main cell is nevus cell

These are large ovoid cells with vesiculated nuclei, and pale cytoplasm

They are derived from neural crest cells










Congenital nevi

Rarer , 1% of neonates

larger and may contain hair

Congenital giant lesions (giant hairy nevus) most often occur in a bathing

trunk distribution or on the chest and back

Develop malignant melanoma in 1 to 5% of the cases

Excision of the nevus is the treatment of choice

Giant cel nevus










Acquired melanocytic nevi

Classified as junctional, compound, or dermal, depending on the location of the nevus cells.

Nevus cells accumulate in the epidermis (junctional), migrate partially into the dermis (compound), and

finally rest completely in the dermis (dermal).

Eventually most lesions undergo involution.

Melanocytes in Normal epithelium










Compound Nevus

- Shows junctional activity & nests

of nevus cells in connective

tissue.

Dysplastic Nevus

Multicolored
Asymmetric pigment

deposition

Asymmetric contour-macular

and papular

Indistinct margins










Atypical mole syndrome-(Dysplastic nevus

syndrome)

>100 melanocytic nevi

1 or more nevi >8mm in

diameter

1 or more dysplastic nevi on

exam

10 year risk of developing melanoma of 14%

Management

Close monitoring- full body exams every 6 months

Dermoscopy of all atypical appearing nevi

The magnified visualization of pigmented skin lesions beyond what would be visible by

the physician

Increases diagnostic accuracy by 10-20%

Excision of any changing or markedly atypical nevi








Melanoma

Melanoma: Pathogenesis

?

Cell of origin: melanocyte

?

Etiology:

? Cumulative and prolonged UVB and/or UVA exposure

? UVA exposure from tanning beds increases risk for melanoma








Risk Factors

? Individual risk factors for development of melanoma

? Increasing age
? Fair skin; blue eyes, red or blond hair; freckling
? Greater than 100 acquired nevi
? Atypical nevi
? Immunosuppression
? Personal or family history of melanoma (two or more 1st degree relatives)
? Ultraviolet exposure: Risk directly related to # of severe blistering sunburns

before puberty; tanning booth use

? Genetic syndromes

Heredity of Melanoma

? 10 % of melanomas are familial and have a genetic basis

? The genes CDKN2A and CDK4 together make up 50% of all

inherited familial cases

? Other identified genes include p53, BRCA2

? 50% of familial melanoma patients have no identified mutation ?

i.e., their genes have not been identified yet












Clinical Manifestations

? May cause symptoms, but usually asymptomatic
? May develop de novo or arise within a pre-existing nevus
? Majority located in sun-exposed areas, but also occur in non-sun-exposed

areas, such as the buttock

? Also occur on mucous membranes (mouth, genitalia)

? Typically appears as a pigmented papule, plaque or nodule.
? Demonstrates any of the ABCDEs

? It may bleed, be eroded or crusted
? Patients may give history of change

The ABCDEs of Melanoma

Suspicious moles may have any of the following features:

ASYMMETRY

? With regard to shape or color

BORDER

? Irregular or notched

COLOR

? Very dark or variegated colors

? Blue, Black, Brown, Red, Pink, White

DIAMETER

? >6 mm, or "larger than a pencil eraser"

? Diameter that is rapidly changing

EVOLVING

? Evolution or change in any of the ABCD features










Superficial Spreading

17

? Superficial spreading type

? Most common type
? Involves back in men; back and

legs in women

? Growth of tumor is primarily

horizontal rather than down into the

dermis

Nodular

18

? Nodular type

? Rapid growth
? Growth is vertical, giving tumor an

increased Breslow's depth

? Breslow's depth = thickness of the primary

melanoma measured from the granular

layer of the epidermis to the deepest part of

the tumor










Lentigo Maligna

19

? Lentigo maligna type

? Occurs on chronically sun-damaged

skin, more common in elderly

patients

? Slow progression
? Growth of tumor is primarily

horizontal, and not vertical

Acral Lentiginous

20

? Acral lentiginous type

? More common in people with darker

skin color (Asians and persons of

African ancestry)

? Diagnosis is often delayed, so

lesions tend to be many centimeters

in diameter










Amelanotic

21

? Amelanotic type

? Morphologic appearance is variable, and the clinical

appearance of pigment is subtle or often absent

? As such, the lesion may be confused with a variety of

benign lesions, such as psoriasis or dermatitis

? This lesion may also be confused with a variety of

malignant lesions, such as squamous cel carcinoma in
situ or basal cel carcinoma

? This is a difficult diagnosis to make, which is why it is

important to biopsy when unsure of the diagnosis

Diagnosis

Biopsy

Excision (Golden standard)
*ncision biopsy
*Punch biopsy
Partial thickness or shaving biopsies are contraindicated

*All dermis layers should be removed












Balch CM, Houghton AN, Sober AJ, Soong S.

Cutaneous Melanoma. St Louis QMP 1998

Staging (AJCC 7th Edition)










Clark Classification

Level I -- the atypical melanocytes are confined to the epidermis (in situ melanoma);

Level II -- the atypical melanocytes have extended into the papil ary dermis but have not

reached the reticular dermis;

Level III -- the atypical melanocytes have penetrated to the interface between the papil ary

dermis and the reticular dermis but do not extend into the reticular dermis;

Level IV -- the atypical melanocytes have extended into the reticular dermis;

Level V -- the atypical melanocytes have reached into the subcutaneous fat.










The histopathologic classification of the Melanoma by Clark

Breslow Classification

Level 1: less than 0.76 mm thick

Level 2: between 0.76? 1.50 mm

Level 3: between 1.50 - 4.00 mm

Level 4: exceed 4.00 mm in thickness

According to the thickness of the lesion as measured by an ocular micrometer from the top of

the granular zone of the epidermis to the base of the neoplasm








Prognostic Factors

n Breslow thickness (most important)

n Clark invasion level

n Ulceration

n Age, sex, location

n Size and surgical margins

n Others (Mitotic index, growth phase, regression.. )

Surgical Treatment

n Biopsy

n Wide Local Excision

n Staging with Sentinel Lymph Node biopsy

n Therapeutic Lymph Node Dissection

n Treatment of Distant Metastasis








Wide Surgical Excision

Suggested surgical margins:

(according to breslow thickness)

In-situ MM:

0.5-1 cm

Breslow thickness < 1mm : 1 cm

Breslow thickness 1-4 mm: 2 cm

Breslow thickness >4 mm: > 3 cm

Sentinel Lymphadenectomy








Sentinel Lymphadenectomy

Sentinel lymph node shows the regional node status

If sentinel lymph node negative, others lymph nodes in the basin are also

negative

If sentinel lymph node contains tumor cel s, It means disease spread to the

regional nodal basin

Sentinel Lymphadenectomy

Sentinel node negative

no additional treatment, follow the patient

Sentinel lymph node positive

Therapeutic lymph node dissection








Advantages of Sentinel Lymphadenectomy

n Provides staging

n Prevention of Elective Lymph node dissection morbidity

Sites of Distant Metastasis

n Skin
n Subcutaneous Tissue
n Distant Lymph Nodes
n Pulmonary
n Liver
n Brain
n Bone
n Intestine




Chemotherapeutic agents



? Melphalan

? Interferon

? Interleukin-2

? Dacarbazine

This post was last modified on 08 April 2022